Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

@article{Ferrer2002GlycogenSK,
  title={Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration},
  author={Isidro Ferrer and M. Barrachina and Berta Puig},
  journal={Acta Neuropathologica},
  year={2002},
  volume={104},
  pages={583-591}
}
Tau phosphorylation was examined in Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) using phospho-specific tau antibodies recognizing the phosphorylated form of Ser202, Ser214 and Ser 396, and antibodies to non-phosphorylated glycogen synthase kinase-3α/β (GSK-3α/β), which regulates phosphorylation at these specific sites on tau and phosphorylated GSK-3βSer9 (GSK-3β-P); this antibody is directed to the inactive form of GSK… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

Activation of JNK / p 38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis

  • C Atzori, B Guetti, +5 authors A Migheli
  • J Neuro - pathol Exp Neurol
  • 2001

Neurodegener - ative tauopathies

  • Lee VMY, M Goedert, JQ Trojanowski
  • Annu Rev Neurosci
  • 2001

Similar Papers

Loading similar papers…